LeMaitre Vascular Announces Q2 2020 Financial Results

Go back to LeMaitre Vascular Announces Q2 2020 Financial Results

Lemaitre Vascular (LMAT) Tops Q2 EPS by 16c, Revenue Beat; Offers 3Q EPS/Revenue Guidance Above Consensus

July 23, 2020 4:29 PM EDT

Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.17, $0.16 better than the analyst estimate of $0.01. Revenue for the quarter came in at $24.9 million versus the consensus estimate of $17.12 million.

Q2 2020 Results

Sales of $24.9mm, -16% (-24% organic) vs. Q2 2019Op. income of $4.9mm,... More